Oral danazol for DME

Retina Today

Volumn , Issue OCTOBER, 2012, Pages 68-70

  Bar Or, David ^a   Thomas, Gregory ^b   Salottolo, Kristin ^b   Orlando, Alessandro ^c   Clift, Vaughan ^b  

^a ST ANTHONY HOSPITAL   (United States)

^b Ampio Pharmaceuticals Inc   (United States)

^c Epidemiologist/statistician   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868327401     PISSN: None     EISSN: 18250572     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci. 2008;1123:134-145.
2. Bogatcheva NV, Verin AD. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res. 2008;76:202-207.
3. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E. Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem. 1995;270:30965-30972.
4. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med. 2009;11:e19.
5. Gavard J, Gutkind JS. VEGF controls enothelial-cell permeabililty by promoting the β-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234.
6. Thomas GW, Rael LT, Shimonkevitz R, Curtis CG, Bar-Or R, Bar-Or D. Effects of danazol on endothelial cell function and angiogenesis. Fertil Steril. 2007;88:1065-1070.
7. Thomas GW, Rael LT, Bar-Or R, et al. Biphasic effect of danazol on human vascular endothelial cell permeability and f-actin cytoskeleton dynamics. Biochem Biophys Res Commun. 2012;421:707-712.